NLRP3 and Parkinson disease: MicroRNA-30e (miR-30e) ameliorates neuroinflammation in the MPTP model of PD by directly targeting NLRP3 and inhibiting the activation of the NLRP3 inflammasome (Li D. et al., 2018).